FAM190A Activators
FAM190A Activators are a diverse group of compounds that impact a variety of cellular signaling pathways and structural elements, which, in turn, can enhance the functional activity of FAM190A. Forskolin, for example, increases cAMP levels that activate PKA, influencing the phosphorylation state of proteins that interact with FAM190A, thereby enhancing its role in cytoskeleton organization. PMA activates PKC, which may phosphorylate substrates that could upregulate FAM190A activity in cytoskeletal integrity. Ionomycin and compounds like it increase intracellular calcium, which activates kinases such as CaMK that might modulate the function of FAM190A. Inhibitors of protein phosphatases like Okadaic Acid and CalyculinA, by preventing dephosphorylation of proteins, can indirectly lead to an enhancement of FAM190A's activity, as phosphorylation is a key regulatory mechanism for many cellular processes including spindle dynamics.
Moreover, inhibitors of specific kinases, such as ZM 447439 and BI 2536, which target Aurora kinase and Plk1 respectively, can also impact FAM190A indirectly. Modifying the phosphorylation state of proteins involved in mitosis through these inhibitors may lead to a requirement for FAM190A's role in chromosomal alignment and segregation to be upregulated as part of a cellular compensatory response to maintain mitotic fidelity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a specific inhibitor of PI3K, leading to a decrease in Akt activation. This decrease can cause a compensatory upregulation of other pathways that support cytoskeletal organization where FAM190A is involved, potentially enhancing its functional activity. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Paclitaxel stabilizes microtubules and prevents their depolymerization, enhancing the mitotic spindle function. Since FAM190A is involved in centrosome and spindle organization, paclitaxel's action can indirectly enhance FAM190A's role in these processes. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Nocodazole disrupts microtubule polymerization, leading to spindle assembly checkpoint activation. This checkpoint activation can enhance the functional activity of FAM190A, which plays a role in the spindle assembly and centrosome integrity. | ||||||
Swinholide A, Theonella swinhoei | 95927-67-6 | sc-205914 | 10 µg | $135.00 | ||
Swinholide A is a potent actin filament depolymerizing agent, leading to changes in the cytoskeleton dynamics. By altering the actin cytoskeleton, Swinholide A can indirectly enhance the activity of FAM190A, which is linked to cytoskeletal regulation. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $91.00 $267.00 | 13 | |
ML-7 is an inhibitor of myosin light chain kinase (MLCK), which is involved in cell contraction and cytoskeleton dynamics. Inhibition of MLCK can lead to altered cytoskeletal dynamics, potentially enhancing the activity of FAM190A in cytoskeleton-related processes. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is an inhibitor of Rho-associated protein kinase (ROCK), which plays a significant role in regulating the cytoskeleton. By inhibiting ROCK, Y-27632 can indirectly enhance the functional activity of FAM190A related to cytoskeleton organization and cell cycle progression. | ||||||
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $184.00 $305.00 | 59 | |
Jasplakinolide stabilizes actin filaments and promotes actin polymerization, affecting cytoskeleton dynamics. Such effects on the actin cytoskeleton can enhance the activity of FAM190A in cytoskeletal organization and cell division. | ||||||
(S)-(−)-Blebbistatin | 856925-71-8 | sc-204253 sc-204253A sc-204253B sc-204253C | 1 mg 5 mg 10 mg 25 mg | $72.00 $265.00 $495.00 $968.00 | ||
Blebbistatin is an inhibitor of non-muscle myosin II ATPase activity, affecting cytoskeleton dynamics and cell migration. By inhibiting myosin II, Blebbistatin can lead to changes in cytoskeletal organization, potentially enhancing the functional activity of FAM190A in maintaining cellular structure. | ||||||